Why Karyopharm Therapeutics Inc (NASDAQ: KPTI) At $1.09 Is Worth Your Money?

Karyopharm Therapeutics Inc (NASDAQ:KPTI) does about 1.36M shares in volume on a normal day but saw 1129909 shares change hands in Friday’s trading. The company now has a market cap of 128.30M USD. Its current market price is $1.09, marking an increase of 1.87% compared to the previous close of $1.07. The 52 week high reached by this stock is $2.79 whilst the lowest price level in 52 weeks is $0.62.

Karyopharm Therapeutics Inc (KPTI) has a 20-day trading average at $1.1183 and the current price is -60.93% off the 52-week high compared with 76.55% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.2805 and its 200-day simple moving average is $1.1526. If we look at the stock’s price movements over the week, volatility stands at 10.95%, which increases to 11.04% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 45.04 to suggest the stock is neutral.

The consensus objective for the share price is $5.21, suggesting that the stock has a potential upside of 79.08% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on January 19, 2023 when Piper Sandler initiated the stock to “Overweight” and issued a price target of $8. RBC Capital Mkts upgraded the stock to “Outperform” from Sector Perform on November 04, 2022 at a price target of $7-$10. JP Morgan upgraded its price target at $8.

Karyopharm Therapeutics Inc (KPTI) stock is down -3.54% over the week and -18.66% over the past month. Its price is 26.01% year-to-date and -59.63% over the past year.

To reach the target analysts have set, the stock logically needs to grow 79.08 percent from here.

The company has a return on investment of -3607.86%. The beta has a value of 0.27. Price to sales ratio is 0.91.